Determinants of Nonadherence to a Single-Dose Nevirapine Regimen for the Prevention of Mother-to-Child HIV Transmission in Rwanda

被引:38
作者
Delvaux, Therese [1 ,2 ]
Elul, Batya [3 ,4 ]
Ndagije, Felix [5 ]
Munyana, Elevanie [6 ]
Roberfroid, Dominique [2 ]
Asiimwe, Anita [6 ]
机构
[1] Inst Trop Med, Dept Microbiol, HIV STI Epidemiol & Control Unit, B-2000 Antwerp, Belgium
[2] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium
[3] Columbia Univ, Int Ctr AIDS Care & Treatment Programs, Mailman Sch Publ Hlth, New York, NY USA
[4] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA
[5] Int Ctr AIDS Care & Treatment Programs, Kigali, Rwanda
[6] Treatment & Res AIDS Ctr, Kigali, Rwanda
关键词
Africa; ARV; HIV; prevention of mother-to-child transmission; prophylaxis; PREGNANT-WOMEN; PMTCT PROGRAM; BURKINA-FASO; SCALING-UP; FOLLOW-UP; ACCEPTABILITY; PARTICIPATION; ZIMBABWE; ABIDJAN; KENYA;
D O I
10.1097/QAI.0b013e31819001a3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: To describe experiences, and identify factors associated with nonadherence to a single-dose nevirapine (SD-NVP) regimen for the prevention of mother-to-child transmission (PMTCT) of HIV in Rwanda. Methods: In April to May 2006, using a case-control design at 12 PMTCT sites, we interviewed HIV-infected women who did not adhere (n = 111) and who adhered (n = 125) to the PMTCT prophylaxis regiment. Nonadherence was defined as mother and/or infant not ingesting SD-NVP at the recommended time or not at all and adherence as mother-infant pairs who ingested it as recommended. Results: Only 61% of nonadherent women had received SD-NVP during pregnancy or delivery. Among nonadherent women who received SD-NVP, 80% ingested it at the recommended time, representing 49% of all nonadherent women. Only 7% of their newborns ingested SD-NVP. Multivariate logistic regression showed that unmarried women, less educated women, women who made 2 or less antenatal care visits. and those offered HIV testing after their first antenatal care visit were more likely to be nonadherent to PMTCT prophylaxis. Not disclosing one's HIV status to someone aside from a partner was also associated with nonadherence in mother-infant pairs. Conclusions: Sociodemographic factors, health services delivery factors, and a lack Of communication and social support contributed to nonadherence to PMTCT prophylaxis in Rwanda.
引用
收藏
页码:223 / 230
页数:8
相关论文
共 28 条
[1]   Predictors of nonadherence to single-dose nevirapine therapy for the prevention of mother-to-child HIV transmission [J].
Albrecht, S ;
Semrau, K ;
Kasonde, P ;
Sinkala, M ;
Kankasa, C ;
Vwalika, C ;
Aldrovandi, GM ;
Thea, DM ;
Kuhn, L .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (01) :114-118
[2]   Barriers to the implementation of programs for the prevention of mother-to-child transmission of HIV: A cross-sectional survey in rural and urban Uganda [J].
Bajunirwe F. ;
Muzoora M. .
AIDS Research and Therapy, 2 (1)
[3]   When do HIV-Infected women disclose their HIV status to their male partner and why? A study in a PMTCT programme, Abidjan [J].
Brou, Hermann ;
Djohan, Gerard ;
Becquet, Renaud ;
Allou, Gerard ;
Ekouevi, Didier K. ;
Viho, Ida ;
Leroy, Valeriane ;
Desgrees-du-Lou, Annabel .
PLOS MEDICINE, 2007, 4 (12) :1912-1920
[4]  
Centers for Disease Control and Prevention (CDC), 2004, MMWR-MORBID MORTAL W, V53, P1083
[5]   Prevention of mother-to-child HIV transmission in resource-poor countries - Translating research into policy and practice [J].
De Cock, KM ;
Fowler, MG ;
Mercier, E ;
de Vincenzi, I ;
Saba, J ;
Hoff, E ;
Alnwick, DJ ;
Rogers, M ;
Shaffer, N .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09) :1175-1182
[6]   Factors influencing acceptability of voluntary counselling and HIV-testing among pregnant women in Northern Tanzania [J].
de Paoli, MM ;
Manongi, R ;
Klepp, KI .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2004, 16 (04) :411-425
[7]   Acceptability and uptake of a package to prevent mother-to-child transmission using rapid HIV testing in Abidjan, Cote d'lvoire [J].
Ekouevi, DK ;
Leroy, V ;
Viho, I ;
Bequet, L ;
Horo, A ;
Rouet, F ;
Sakarovitch, C ;
Welffens-Ekra, C ;
Dabis, F .
AIDS, 2004, 18 (04) :697-700
[8]   Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVMET 012 randomised trial [J].
Guay, LA ;
Musoke, P ;
Fleming, T ;
Bagenda, D ;
Allen, M ;
Nakabiito, C ;
Sherman, J ;
Bakaki, P ;
Ducar, C ;
Deseyve, M ;
Emel, L ;
Mirochnick, M ;
Fowler, MG ;
Mofenson, L ;
Miotti, P ;
Dransfield, K ;
Bray, D ;
Mmiro, F ;
Jackson, JB .
LANCET, 1999, 354 (9181) :795-802
[9]   Home deliveries: Implications for adherence to nevirapine in a PMTCT programme in rural Malawin [J].
Kasenga, F. ;
Hurtig, A.-K. ;
Emmelin, M. .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2007, 19 (05) :646-652
[10]   Compliance with antiretroviral regimens to prevent perinatal HIV-1 transmission in Kenya [J].
Kiarie, JN ;
Kreiss, JK ;
Richardson, BA ;
John-Stewart, GC .
AIDS, 2003, 17 (01) :65-71